Every month, the Financial X-Ray evaluates more than 800 publicly listed companies through the same systematic process. Only a small fraction qualify for the Financial X-Ray Selection – the portfolio that has consistently outperformed the MSCI World since inception by focusing on business quality, financial strength, management execution, growth and valuation rather than headlines or market sentiment.
Most investors assume successful investing is about buying companies before everyone else discovers them.
I don’t think that’s true.
When the Financial X-Ray was built, the idea was never to identify the next 30-bagger or predict the next market trend - not because I wouldn’t love to know it – simply because I can’t do it with confidence. Instead, I focused on a much simpler question:
Has this business demonstrated enough financial quality to deserve a place in a concentrated long-term portfolio?
That distinction matters.
Buying too early often means investing in hope. Buying too late means paying for perfection. The Financial X-Ray attempts to sit somewhere in the middle – waiting patiently until the financial evidence becomes compelling while the valuation still provides attractive long-term upside.
This week I’d like to show you exactly how that decision process works.
Not by discussing the algorithm itself.
But by walking through one company that eventually qualified for the Financial X-Ray Selection.
Every company entering the Financial X-Ray Selection must satisfy a demanding set of criteria.
Financial health must be robust enough to withstand difficult markets.
Management must demonstrate disciplined capital allocation.
Growth prospects cannot be weak.
Valuation must still provide sufficient upside despite the company’s quality.
Most importantly, the overall assessment must be Strong.
No single ratio determines the outcome.
A low P/E ratio alone doesn’t qualify a company. High revenue growth alone doesn’t qualify a company. Even excellent profitability isn’t enough if investors have already priced in years of perfection.
The Financial X-Ray weighs all of these characteristics together.
That is why relatively few businesses make the final portfolio.
The stock I’d like to discuss is up 450% since June 2023 and has delivered well on all criteria.
Let’s look at the financial evidence.
The first metric I always study is profitability.
Many industrial businesses generate EBITDA margins between 10% and 20%. Businesses consistently exceeding that range usually possess some combination of pricing power, operational efficiency or competitive advantages that weaker competitors struggle to replicate.
In this case, EBITDA margins steadily expanded over several years.
That tells us far more than “profits increased.”
It suggests management wasn’t merely benefiting from higher demand. They were improving the underlying economics of the business – earning more operating profit from every dollar of revenue through better product mix, stronger pricing and greater operating leverage.
The next characteristic is capital efficiency.
Return on Equity measures how effectively management converts shareholder capital into profits.
For many mature industrial businesses, returns above 15% are considered healthy. Above 20% generally indicates a business with durable competitive advantages.
The company consistently moved into that territory.
Importantly, those returns weren’t created by excessive borrowing.
The balance sheet strengthened at the same time.
Net debt declined steadily, reducing financial risk while improving flexibility for future investment.
That’s exactly the type of combination the Financial X-Ray rewards.
High returns are impressive.
High returns supported by a conservative balance sheet are considerably more valuable.
Cash generation also improved.
Accounting profits can fluctuate because of one-off adjustments or accounting assumptions.
Free cash flow is much harder to manipulate.
Growing free cash flow demonstrates that reported earnings are increasingly converting into real cash that management can reinvest, reduce debt or return to shareholders.
Finally comes valuation.
This is often the most misunderstood part of investing.
Many investors assume a low multiple automatically means a stock is attractive.
It doesn’t.
Equally, an expensive multiple doesn’t automatically make a stock overvalued.
Quality businesses frequently deserve premium valuations because they generate superior returns for many years.
The Financial X-Ray therefore doesn’t ask whether valuation is cheap.
It asks whether today’s valuation is still justified by the underlying quality of the business.
By June 2023, the answer had become yes.
The financial evidence had improved consistently across multiple years.
The company finally earned its place in the Financial X-Ray Selection.
An industrial company without hype, without market noise and with constantly improving financial quality - that is rare, but exactly the kind of business that performs well.
Behind the paywall I’ll reveal the company we just discussed. Paid subscribers get access to the full X-Ray Selection and get to screen more than 800 stocks for attractive investment opportunities.
